TY  - GEN
AU  - Zhuang,Li
AU  - Mou,Hai-Bo
AU  - Yu,Lan-Fang
AU  - Zhu,Heng-Kai
AU  - Yang,Zhe
AU  - Liao,Qin
AU  - Zheng,Shu-Sen
TI  - Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation
SN  - 1499-3872
PY  - 2020///1210
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Brain Neoplasms
KW  - secondary
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Chemoembolization, Therapeutic
KW  - Fatal Outcome
KW  - Hepatectomy
KW  - Humans
KW  - Immune Checkpoint Inhibitors
KW  - Liver Neoplasms
KW  - Liver Transplantation
KW  - adverse effects
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Programmed Cell Death 1 Receptor
KW  - antagonists & inhibitors
N1  - Publication Type: Case Reports; Letter
UR  - https://doi.org/10.1016/j.hbpd.2019.09.011
ER  -